Condition: Huntington's Disease · Sponsor: Sarepta Therapeutics, Inc.
This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).
This description comes directly from the study's public registry record.
Sarepta Therapeutics Inc., For Clinical Trial Information, Select Option 4 · 1-888-SAREPTA (1-888-727-3782) · SareptAlly@sarepta.com
Always discuss trial participation with your own doctor first.
| Pacific Clinical Research Network - Auckland (PCRN Auckland) | Auckland, New Zealand | Not Yet Recruiting |
| New Zealand Brain Research Institute | Christchurch, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07536061